ID: ALA4797414

Max Phase: Preclinical

Molecular Formula: C21H27NO3

Molecular Weight: 341.45

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccc(CNC(=O)C(C)c2ccc(CC(C)C)cc2)cc1O

Standard InChI:  InChI=1S/C21H27NO3/c1-14(2)11-16-5-8-18(9-6-16)15(3)21(24)22-13-17-7-10-20(25-4)19(23)12-17/h5-10,12,14-15,23H,11,13H2,1-4H3,(H,22,24)

Standard InChI Key:  BLERDCRAMCUCSJ-UHFFFAOYSA-N

Associated Targets(non-human)

Anandamide amidohydrolase 3907 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 341.45Molecular Weight (Monoisotopic): 341.1991AlogP: 4.02#Rotatable Bonds: 7
Polar Surface Area: 58.56Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.85CX Basic pKa: CX LogP: 4.52CX LogD: 4.52
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.80Np Likeness Score: -0.31

References

1. Tripathi RKP.  (2020)  A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents.,  188  [PMID:31945644] [10.1016/j.ejmech.2019.111953]

Source